Cargando…

Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats

SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated as...

Descripción completa

Detalles Bibliográficos
Autores principales: Escribano, Damián, Bustillo, Alba Ortín, Marín, Luis Pardo, Rabasco, Andrea Navarro, Herrera, Pablo Ruiz, Cerón, Jose J., Tvarijonaviciute, Asta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469286/
https://www.ncbi.nlm.nih.gov/pubmed/34573484
http://dx.doi.org/10.3390/ani11092518
_version_ 1784573892067590144
author Escribano, Damián
Bustillo, Alba Ortín
Marín, Luis Pardo
Rabasco, Andrea Navarro
Herrera, Pablo Ruiz
Cerón, Jose J.
Tvarijonaviciute, Asta
author_facet Escribano, Damián
Bustillo, Alba Ortín
Marín, Luis Pardo
Rabasco, Andrea Navarro
Herrera, Pablo Ruiz
Cerón, Jose J.
Tvarijonaviciute, Asta
author_sort Escribano, Damián
collection PubMed
description SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated assay previously validated in cats, although one of them did not show an optimal precision. Both assays were able to detect higher SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases. In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. ABSTRACT: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for SAA measurements in cats (FUJI DRI-CHEM IMMUNO AU CARTRIDGE vf-SAA (method A), and CUBE-VET analyser (Method B), were analytically evaluated. Regarding the imprecision precision only the method A showed intra-assay and inter-assay CV < 10% at all concentrations. Both assays showed linearity with r close to 1 and the recovery were in the range of 81–112% for assay A and 85–125% for assay B and the limit of detection were 3.75 and 0.5 mg/dL for method A and B, respectively. A previously validated method for SAA quantification SAATIA; LZ-SAA (method C) was used as gold-standard to evaluate the accuracy of the assays. Significant correlations (p < 0.0001) were found between assays A and C (r = 0.94) and B and C (r = 0.91). In addition, an overlap performance test was made using serum samples from cats with non-inflammatory and cats with inflammatory. Both assays showed higher median SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases (p < 0.0001). In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats.
format Online
Article
Text
id pubmed-8469286
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84692862021-09-27 Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats Escribano, Damián Bustillo, Alba Ortín Marín, Luis Pardo Rabasco, Andrea Navarro Herrera, Pablo Ruiz Cerón, Jose J. Tvarijonaviciute, Asta Animals (Basel) Communication SIMPLE SUMMARY: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for serum amyloid A measurements in cats were analytically evaluated. The two assays were accurate and showed significant correlations with an automated assay previously validated in cats, although one of them did not show an optimal precision. Both assays were able to detect higher SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases. In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. ABSTRACT: Serum Amyloid A (SAA) is one of the most sensitive tests to detect inflammation in cats. In this study, two point-of-care assays for SAA measurements in cats (FUJI DRI-CHEM IMMUNO AU CARTRIDGE vf-SAA (method A), and CUBE-VET analyser (Method B), were analytically evaluated. Regarding the imprecision precision only the method A showed intra-assay and inter-assay CV < 10% at all concentrations. Both assays showed linearity with r close to 1 and the recovery were in the range of 81–112% for assay A and 85–125% for assay B and the limit of detection were 3.75 and 0.5 mg/dL for method A and B, respectively. A previously validated method for SAA quantification SAATIA; LZ-SAA (method C) was used as gold-standard to evaluate the accuracy of the assays. Significant correlations (p < 0.0001) were found between assays A and C (r = 0.94) and B and C (r = 0.91). In addition, an overlap performance test was made using serum samples from cats with non-inflammatory and cats with inflammatory. Both assays showed higher median SAA concentrations in cats with inflammatory diseases than in cats without inflammatory diseases (p < 0.0001). In conclusion, this manuscript provides data about the possible application of two point-of-care assays for the measurement of SAA concentration in cats. MDPI 2021-08-27 /pmc/articles/PMC8469286/ /pubmed/34573484 http://dx.doi.org/10.3390/ani11092518 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Escribano, Damián
Bustillo, Alba Ortín
Marín, Luis Pardo
Rabasco, Andrea Navarro
Herrera, Pablo Ruiz
Cerón, Jose J.
Tvarijonaviciute, Asta
Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title_full Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title_fullStr Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title_full_unstemmed Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title_short Analytical Validation of Two Point-of-Care Assays for Serum Amyloid A Measurements in Cats
title_sort analytical validation of two point-of-care assays for serum amyloid a measurements in cats
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469286/
https://www.ncbi.nlm.nih.gov/pubmed/34573484
http://dx.doi.org/10.3390/ani11092518
work_keys_str_mv AT escribanodamian analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT bustilloalbaortin analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT marinluispardo analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT rabascoandreanavarro analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT herrerapabloruiz analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT ceronjosej analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats
AT tvarijonaviciuteasta analyticalvalidationoftwopointofcareassaysforserumamyloidameasurementsincats